| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Brent H. Zettl CEO | OTC PINK Exchange | CA9899601095 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
ZYUS Life Sciences Corporation is a pioneering firm in the phyto-therapeutic and cannabis-based medicine industry with global operations. Since its incorporation in 1944, ZYUS has been committed to the development, manufacture, and distribution of cannabinoid-based therapeutics and products. The company prides itself on its innovative approach to healthcare, aiming to enhance the quality of life for patients worldwide. Operating out of Saskatoon, Canada, ZYUS Life Sciences Corporation leverages its extensive experience and research capabilities to deliver high-quality, effective solutions in the realm of cannabinoid medicine.
ZYUS Life Sciences Corporation offers a variety of cannabinoid-based oils, designed to provide patients with precise dosing options for oral consumption. These oils are formulated to ensure high purity and consistency, aiming to offer relief and therapeutic benefits for various conditions.
The company produces gel-caps as an alternative to traditional oral cannabinoid applications. These gel-caps provide a convenient, discreet, and easy-to-use option for medication intake, ensuring consistent dosage and efficacy for patients seeking pain relief, anti-inflammatory effects, or other therapeutic benefits associated with cannabinoids.
Additionally, ZYUS offers topical creams infused with cannabinoids for patients preferring localized treatment options. These creams are designed to target specific areas of discomfort, providing relief from pain and inflammation without the systemic effects associated with oral medications. This product line reflects ZYUS's commitment to diversifying its offerings to meet the unique needs of its customer base.